Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018
Fri, March 9, 2018
Thu, March 8, 2018
Wed, March 7, 2018
Tue, March 6, 2018
Mon, March 5, 2018
Fri, March 2, 2018
Thu, March 1, 2018
Wed, February 28, 2018
Tue, February 27, 2018
Mon, February 26, 2018
Fri, February 23, 2018

Ian Somaiya Maintained (BIIB) at Buy with Decreased Target to $393 on, Mar 5th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-393-on-mar-5th-2018.html
Published in Stocks and Investing on by   Print publication without navigation


Ian Somaiya of BMO Capital, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $403 to $393 on, Mar 5th, 2018.

Ian has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 1 agrees with Ian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $350 on, Wednesday, January 24th, 2018


These are the ratings of the 4 analyists that currently disagree with Ian


  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $433 on, Monday, February 5th, 2018
  • Carter Gould of "UBS" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Friday, January 26th, 2018
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $363 on, Friday, January 26th, 2018